期刊
THERAPEUTIC DELIVERY
卷 1, 期 2, 页码 273-287出版社
FUTURE SCI LTD
DOI: 10.4155/TDE.10.24
关键词
-
资金
- State Key Development Plan Project [2006CB10901, 2007CB935801, 2006CB933305]
- National Natural Science Foundation of China [90606019, 30901869]
- Chinese Academy of Sciences Project [KSCX1-YW-R-21]
- China-Finland Inter-Governmental S&T cooperation project [2008DFA01510]
- National Science and Technology Special Project of Major New Drugs Creation [2009ZX09501-025]
Doxorubicin (DOX) is one of the most active anticancer drugs, while its cumulative dose-dependent side effects compromise the anticancer efficacy. Nanoparticles, an emerging platform for cancer therapy, have been shown to increase intracellular uptake of DOX with reduced side effects compared with conventional DOX formulations. While large numbers of clinical and preclinical studies have been published, the purpose of this review is to draw attention to the developments of DOX-loaded nanoparticles for cancer therapy, with special a focus on enhanced intracellular uptake and reduced side-effects strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据